The decrease of the maximum standardized uptake value of the primary tumor corrected for lean body mass (SULmax) was moderately predictive of pCR in hormone receptor negative/HER2-positive breast cancer (ROC AUC 0.76, 90% CI 0.67–0.85)72. This evidence concerns the gene ERBB2 and breast cancer.